CLINICAL_TRIALS trial_result · 2015-01-16

Clinical Trial Update: Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children [Phase 2]

Phase 2 clinical trial update on treating newly diagnosed high-risk acute lymphoblastic leukemia in children; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: The Korean Society of Pediatric Hematology Oncology | Conditions: Acute Lymphoblastic Leukemia, Child | Phase 2 | Status: UNKNOWN